Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rahal

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Microbial Drug Resistance (Larchmont, N.Y.)|January 11, 2008
Identification of carbapenem-resistant klebsiella pneumoniae harboring KPC enzymes in New JerseyTom Chiang, Noriel Mariano, Carl Urban, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2004
Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York CityPatricia A Bradford, Simona Bratu, Carl Urban, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long-term care facilitiesCarl Urban, Patricia A Bradford, Margareta Tuckman, et al.
Innovations (Philadelphia, Pa.)|January 15, 2015
Asymmetric sternotomy and sternal wound complications: assessment using 3-dimensional computed tomography reconstructionJoshua Y Jacobson, Matthew E Doscher, William J Rahal, et al.
Antimicrobial Agents and Chemotherapy|May 27, 2005
Fluoroquinolone-resistant Streptococcus agalactiae: epidemiology and mechanism of resistanceWehbeh Wehbeh, Roberto Rojas-Diaz, Xinying Li, et al.
The Journal of Infectious Diseases|February 1, 1985
Amikacin-resistant gram-negative bacilli: correlation of occurrence with amikacin useJ F Levine, M J Maslow, R E Leibowitz, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1983
Ceftazidime therapy of infections caused by Enterobacteriaceae and Pseudomonas aeruginosaM J Maslow, A Rosenberg, A A Pollock, et al.
JAMA|October 24, 1998
Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial KlebsiellaJ J Rahal, C Urban, D Horn, et al.
Diagnostic Microbiology and Infectious Disease|January 20, 2012
Identification of CTX-M β-lactamases among Escherichia coli from the community in New York CityHemavarna Tiruvury, James R Johnson, Noriel Mariano, et al.
Diagnostic Microbiology and Infectious Disease|March 16, 2010
Identification of CTX-M beta-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilitiesCarl Urban, Noriel Mariano, Patricia A Bradford, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Microbial Drug Resistance (Larchmont, N.Y.)|January 11, 2008
Identification of carbapenem-resistant klebsiella pneumoniae harboring KPC enzymes in New JerseyTom Chiang, Noriel Mariano, Carl Urban, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2004
Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York CityPatricia A Bradford, Simona Bratu, Carl Urban, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long-term care facilitiesCarl Urban, Patricia A Bradford, Margareta Tuckman, et al.
Innovations (Philadelphia, Pa.)|January 15, 2015
Asymmetric sternotomy and sternal wound complications: assessment using 3-dimensional computed tomography reconstructionJoshua Y Jacobson, Matthew E Doscher, William J Rahal, et al.
Antimicrobial Agents and Chemotherapy|May 27, 2005
Fluoroquinolone-resistant Streptococcus agalactiae: epidemiology and mechanism of resistanceWehbeh Wehbeh, Roberto Rojas-Diaz, Xinying Li, et al.
The Journal of Infectious Diseases|February 1, 1985
Amikacin-resistant gram-negative bacilli: correlation of occurrence with amikacin useJ F Levine, M J Maslow, R E Leibowitz, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1983
Ceftazidime therapy of infections caused by Enterobacteriaceae and Pseudomonas aeruginosaM J Maslow, A Rosenberg, A A Pollock, et al.
JAMA|October 24, 1998
Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial KlebsiellaJ J Rahal, C Urban, D Horn, et al.
Diagnostic Microbiology and Infectious Disease|January 20, 2012
Identification of CTX-M β-lactamases among Escherichia coli from the community in New York CityHemavarna Tiruvury, James R Johnson, Noriel Mariano, et al.
Diagnostic Microbiology and Infectious Disease|March 16, 2010
Identification of CTX-M beta-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilitiesCarl Urban, Noriel Mariano, Patricia A Bradford, et al.
Pageof 10